Pharma & Life Sciences

APASL - Asian Pacific Association for the Study of the Liver

The 36th Annual Meeting of APASL 2027, held from April 1-4, 2027, in Sydney, is Asia-Pacific’s premier liver conference. It focuses on advancing research, prevention, and treatment of liver diseases for the global liver community.

6 months until it opens.

The essentials

Event details

Dates
1 April 2027 to 4 April 2027
Organiser
Asia Pacific Society for the Study of the Liver
Expected attendance
4,200
Industry
Pharma & Life Sciences

Agenda themes

Topics covered

  • MAFLD
  • HBV
  • HCV
  • HCC
  • Basic and Translational Research
  • Endo Hepatology
  • Cholestatic Liver Disease
  • Portal Hypertension
  • DILI
  • Transplant

On stage

Speakers

  • Jacob GeorgePresident, APASL
  • Amany ZekryCo-Chair
  • Jess Howell
  • Alex ThompsonPresident, Gastroenterological Society of Australia

Logistics

Where to stay

Places to stay near the venue.

Stay on it

Get the next edition

When APASL - Asian Pacific Association for the Study of the Liver announces its next edition, or these dates change, we read it from the organiser's own site. One email when that happens, nothing else.

One email per announcement. Unsubscribe in a click, and we never pass your address on.

Plan this event

Work out who to meet here

Luminik sources the attendee picture for an event like APASL - Asian Pacific Association for the Study of the Liver, enriches it against your ICP, and sequences it ahead of the date. Capture at the event writes to Salesforce or HubSpot the same day, and attribution ties the pipeline back to the spend.

Spot something wrong on this page? Report a correction and we will fix it.

Is this your event? Verify it with your work email: one click in your inbox proves it is yours, we approve, and the badge goes up, usually within a day. Prefer the form?

If your email matches the event's own domain, one click in your inbox completes your side; we approve and the badge goes up, usually within a day. Otherwise we check by hand, same as always.